Bard Financial Services Inc. raised its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY – Free Report) by 37.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 110,850 shares of the company’s stock after buying an additional 30,350 shares during the period. Bard Financial Services Inc.’s holdings in Roche were worth $3,866,000 as of its most recent SEC filing.
A number of other hedge funds have also added to or reduced their stakes in RHHBY. Confluence Investment Management LLC increased its stake in Roche by 26.3% in the 4th quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock valued at $488,000 after buying an additional 2,910 shares during the last quarter. IHT Wealth Management LLC bought a new stake in Roche during the third quarter worth $236,000. Brooklyn Investment Group purchased a new position in shares of Roche in the 3rd quarter worth about $40,000. Canopy Partners LLC grew its position in Roche by 4.6% during the third quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock valued at $310,000 after buying an additional 344 shares during the period. Finally, Verity Asset Management Inc. purchased a new stake in Roche during the third quarter worth about $253,000.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on RHHBY shares. Deutsche Bank Aktiengesellschaft lowered shares of Roche from a “hold” rating to a “sell” rating in a research note on Friday, September 13th. Bank of America raised Roche from a “neutral” rating to a “buy” rating in a research report on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold”.
Roche Stock Performance
Shares of OTCMKTS RHHBY traded up $0.24 during midday trading on Monday, hitting $35.18. The company’s stock had a trading volume of 1,384,172 shares, compared to its average volume of 1,047,586. The stock has a fifty day moving average price of $36.28 and a 200 day moving average price of $37.96. Roche Holding AG has a one year low of $29.20 and a one year high of $42.43.
Roche Profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Read More
- Five stocks we like better than Roche
- Investing In Automotive Stocks
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- With Risk Tolerance, One Size Does Not Fit All
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Best Stocks Under $5.00
- How Cigna Remains at the Top of the Health Insurance Food Chain
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY – Free Report).
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.